Liraglutide
Also known as: Victoza, Saxenda FDA-approved GLP-1 receptor agonist for type 2 diabetes and obesity. Extensive clinical trial evidence. 📖
n
Skip to contentAlso known as: Victoza, Saxenda FDA-approved GLP-1 receptor agonist for type 2 diabetes and obesity. Extensive clinical trial evidence. 📖
Also known as: Lupron, Eligard Leuprolide is a synthetic version of a brain hormone that controls sex hormone production—but it
Also known as: Pentapeptide-18 Stabilized enkephalin analog (Tyr-D-Ala-Gly-Phe-Leu) targeting opioid receptors on motor nerve terminals to reduce NMJ excitability. Mechanistically
Also known as: AT-1001 Larazotide is a synthetic peptide designed to keep your gut lining sealed. 📖 Read the full
Also known as: Somatuline Lanreotide is an FDA-approved peptide drug that treats hormone-producing tumors and a growth hormone disorder called
Klotho is a large protein your body makes on its own. 📖 Read the full Klotho research overview → Evidence
Kisspeptin is the master switch for human reproduction. 📖 Read the full Kisspeptin-10 research overview → Evidence Tier: Tier 2
Also known as: Kepivance FDA-approved for oral mucositis (Kepivance). FGFR2b-mediated follicle keratinocyte proliferation is well-characterized, but no clinical trials exist
The most selective growth hormone-releasing peptide in published research. Ipamorelin triggers GH release without elevating cortisol, ACTH, or prolactin—a selectivity
Growth factor mediating many of GH’s effects on tissues including hair follicles. WADA-prohibited. Systemic administration carries hypoglycemia risk—follicle-level delivery remains